DENISE LEDOUX: Open Payments
NPI 1568473379 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 11 payments from 8 companies in 2025. Trend: 2023 $249 · 2024 $153 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| American Regent | 1 | $67 |
| BridgeBio Pharma, Inc. | 1 | $57 |
| PFIZER INC. | 2 | $56 |
| HEARTFLOW, INC. | 1 | $47 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Novo Nordisk Inc | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
Products named: INJECTAFER, Attruby, FFRct, VERQUVO, LifeVest, Wegovy, ELIQUIS, VYNDAQEL.
Industry payments across WA — which companies pay providers there.
